S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%
Next Bullish Trade
Sign in
A

Agilent Technologies, Inc. A

$131.46 -4.64 (-3.41%)
Neutral · -0.17σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · A

Momentum reads · latest daily bar
Last
$131.46
-4.64 (-3.41%)
Mkt cap
$37.1B
Healthcare
RSI(14)
50.3
neutral
Stochastic %K
63.8
neutral
MFI(14)
48.0
neutral
ADX(14)
16.0
weak trend

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-04-30 $1.8B $0.3B $0.4B $0.2B 18.5% 21.7%
2026-01-31 $1.8B $0.3B $0.4B $0.2B 17.0% 19.6%
2025-10-31 $1.9B $0.4B $0.4B $0.5B 23.3% 23.8%
2025-07-31 $1.7B $0.3B $0.4B $0.3B 19.3% 20.7%
2025-04-30 $1.7B $0.2B $0.3B $0.1B 12.9% 18.0%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare A vs peers

Line A up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing A no peers yet — add up to 4 below

Add tickers to compare with A

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 0 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

No earnings history available.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
A $37B 26.4 19.9 5.1 19.3 5.2 52.6% 10.0% 60.0% 2.51%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 42.03%

HolderShares% out
Blackrock Inc. 25,902,662 9.17%
Vanguard Capital Management LLC 18,381,030 6.51%
Vanguard Portfolio Management LLC 14,352,682 5.08%
State Street Corporation 12,764,632 4.52%
Massachusetts Financial Services Co. 12,624,090 4.47%
T. Rowe Price Investment Management, 8,992,649 3.18%
Geode Capital Management, LLC 7,522,028 2.66%
Wellington Management Group, LLP 7,256,433 2.57%
Deutsche Bank AG 5,984,118 2.12%
Morgan Stanley 4,949,129 1.75%

Insider activity · 90d

1 buys / 1 sells · ratio 1.0 · Finnhub

  • MCDONNELL PADRAIG F 65,842 @ $137.40
  • Dolsten Mikael SELL 5,548 @ $135.42
  • Buckner Michael Steven BUY 8,887
  • MAY SIMON F 14,015 @ $115.62

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$135.0
Mean
$159.3158
High
$185.0
Analysts
19
Recommendation distribution · period 2026-07-01
8
15
6
Revision trend (2026-04-01 → 2026-07-01): net 22 → 23 +1 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-06-29 PRIMARY DOCUMENT view ·
8-K 2026-06-25 8-K view ·
4 2026-06-05 PRIMARY DOCUMENT view ·
4 2026-06-02 PRIMARY DOCUMENT view ·
10-Q 2026-06-01 10-Q view ·
8-K 2026-05-27 8-K view ·
4 2026-05-21 PRIMARY DOCUMENT view ·
4 2026-05-12 PRIMARY DOCUMENT view ·
8-K 2026-05-04 8-K view ·
8-K 2026-04-03 8-K view ·
4 2026-04-02 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
4 2026-03-23 PRIMARY DOCUMENT view ·
8-K 2026-03-20 8-K view ·
8-K 2026-03-06 8-K view ·
10-Q 2026-03-03 10-Q view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
8-K 2026-02-25 8-K view ·
DEF 14A 2026-02-06 DEF 14A view ·
10-K 2025-12-22 10-K view ·
4 2025-12-03 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-12-01 PRIMARY DOCUMENT view ·
4 2025-11-25 PRIMARY DOCUMENT view ·
4 2025-11-25 PRIMARY DOCUMENT view ·
4 2025-11-25 PRIMARY DOCUMENT view ·
4 2025-11-25 PRIMARY DOCUMENT view ·
4 2025-11-25 PRIMARY DOCUMENT view ·
8-K 2025-11-24 8-K view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-20 PRIMARY DOCUMENT view ·
4 2025-11-18 PRIMARY DOCUMENT view ·
4 2025-11-18 PRIMARY DOCUMENT view ·
4 2025-11-18 PRIMARY DOCUMENT view ·
4 2025-11-18 PRIMARY DOCUMENT view ·
4 2025-11-18 PRIMARY DOCUMENT view ·
4 2025-11-14 PRIMARY DOCUMENT view ·
8-K 2025-10-27 8-K view ·

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab l…

Options picks · A

ITM + OTM ideas from the latest scan

Loading…

Congress trades · A

STOCK Act disclosures

Loading…

SEC filings & insiders · A

EDGAR · live

Loading…

Holders · A

Institutions & insider activity

Loading…